Abstract LB313: EGFRvIII-targeted alpha therapy shows significant therapeutic efficacy as both a single-agent and in combination with standard of care against preclinical GBM models Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Metcalf, Julie
  • Nielsen, Alexander
  • Prabhu, Suma
  • Robinson, Nicole
  • Marinacci, Sarah
  • Grinshtein, Natalie
  • Theriault, Brigitte L
  • Marcil, Anne
  • Jaramillo, Maria L
  • Sulea, Traian
  • Lessard, Ivan A
  • Moreno, Maria
  • Leamon, Christopher P
  • Burak, Eric
  • Valliant, John F

publication date

  • April 14, 2023